Connect with us

Politics

Senate Report Slams Drug Scheduling System For Blocking Marijuana Research

Published

on

A Senate committee released a draft spending report on Wednesday that expresses concern about barriers to marijuana research and calls for increased research on two cannabis compounds, CBD and CBG.

On the other hand, the appropriations bill that the report is attached to also contains a long-standing rider prohibiting the use of funds for “any activity that promotes the legalization” of Schedule I drugs—a provision that Rep. Alexandria Ocasio-Cortez (D-NY) unsuccessfully attempted to remove from the House version of the spending legislation earlier this year in order to encourage studies on psychedelics.

Although the language prohibiting the promotion of legalizing controlled substances wasn’t dropped, the Senate Appropriations Committee did express concern in its report that “restrictions associated with Schedule I of the Controlled Substance Act effectively limit the amount and type of research that can be conducted on certain Schedule I drugs, especially marijuana or its component chemicals, and new synthetic drugs and analogs.”

“At a time when we need as much information as possible about these drugs to find antidotes for their harmful effects, we should be lowering regulatory and other barriers to conducting this research,” the panel said, adding that it wants the National Institute on Drug Abuse to submit a report “on the barriers to research that result from the classification of drugs and compounds as Schedule I substances” within 120 days of enactment.

While past committee reports have included similar language concerning the impact of the federal drug scheduling system on marijuana research and the need for more information about CBD, this appears to be the first time that such a report has mentioned CBG, a lesser-known non-intoxicating compound commonly found in low-THC cannabis varieties, including hemp.

“The Committee believes that cannabidiol [CBD] and cannabigerol [CBG], compounds found in cannabis, may provide beneficial medicinal effects,” the report on the Fiscal Year 2020 Labor-HHS-Education appropriations bill states. “However, there is insufficient scientific information about the long-term effects of these compounds.”

“Additional, coordinated research on a national scale could help determine the toxicology and medicinal effects of CBD and CBG,” it continues. “The Committee encourages [the National Institutes of Health] to consider additional investment in studying the medicinal effects and toxicology of CBD and CBG.”

There were a number of marijuana-related recommendations attached to House spending reports earlier this year, including one encouraging the Food and Drug Administration to create a regulatory pathway for CBD to be marketed in food items and as dietary supplements, another urging funding so that the U.S. Department of Agriculture can expediently develop rules for hemp and one expressing concern about impaired driving from THC.

A separate report contained language directing the Drug Enforcement Administration (DEA) to take action on applications for additional federally authorized marijuana manufacturers for research purposes. DEA said in August that it is taking steps to get those requests approved.

The House Appropriations Committee also advised that the U.S. Office of Personnel Management update its guidelines for hiring and firing individuals solely because they use cannabis in a state where it’s legal.

The most consequential cannabis rider the House approved in appropriations legislation this year was a measure blocking the Justice Department from using its funds to interfere in state-legal marijuana programs, both for medical and adult use. It remains to be seen whether the Republican-controlled Senate will follow suit, however.

Read the full text of the Senate committee’s two cannabis-specific recommendations below:

Barriers to Research—The Committee is concerned that restrictions associated with Schedule I of the Controlled Substance Act effectively limit the amount and type of research that can be conducted on certain Schedule I drugs, especially marijuana or its component chemicals, and new synthetic drugs and analogs. At a time when we need as much information as possible about these drugs to find antidotes for their harmful effects, we should be lowering regulatory and other barriers to conducting this research. The Committee directs NIDA to provide a brief report on the barriers to research that result from the classification of drugs and compounds as Schedule I substances no later than 120 days after enactment.

Cannabis Research—The Committee believes that cannabidiol [CBD] and cannabigerol [CBG], compounds found in cannabis, may provide beneficial medicinal effects. However, there is insufficient scientific information about the long-term effects of these compounds. Additional, coordinated research on a national scale could help determine the toxicology and medicinal effects of CBD and CBG. The Committee encourages NIH to consider additional investment in studying the medicinal effects and toxicology of CBD and CBG.

Read the full text of the rider banning the promotion of legalizing Schedule I substances below:

SEC. 509. (a) None of the funds made available in this Act may be used for any activity that promotes the legalization of any drug or other substance included in schedule I of the schedules of controlled substances established under section 202 of the Controlled Substances Act except for normal and recognized executive-congressional communications.

Civil Rights Groups Urge Congress To Delay Marijuana Banking Vote

Photo courtesy of Evan Johnson.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Sacramento-based senior editor. His work has also appeared in High Times, VICE and attn.

Politics

New York Doctors Can Now Recommend Medical Marijuana To Patients For Any Condition They See Fit

Published

on

As New York prepares the launch of its adult-use marijuana market, the state Office of Cannabis Management (OCM) announced on Monday a significant expansion of the existing medical cannabis program.

Now doctors will be able to issue medical marijuana recommendations to people for any condition that they feel could be treated by cannabis, rather than rely on a list of specific eligible maladies. Physicians were granted that discretion through the state’s recreational marijuana law that was enacted last year.

The expansion is being made possible as part of OCM’s new Medical Cannabis Program certification and registration system.

“It is terrific to see the Medical Cannabis Program expand so vastly with the launch of the new certification and registration program and the ability of practitioners to determine qualifying conditions as included in the MRTA,” Cannabis Control Board (CCB) Chair Tremaine Wright said in a press release.

“The new cannabis industry is taking shape as we continue to implement the MRTA and provide greater access for New Yorkers to a medicine that we’re learning more about every day,” Wright said. “We’re continuing to move forward swiftly and today’s system launch follows our achievements that already include adding whole flower medical product sales, permanently waiving $50 patient fees, and advancing home cultivation regulations, among others.”

Lat last year, CCB voted unanimously to advance a policy change to allow medical cannabis patients in the state to grow plants for personal use, another change made possible by the broad legalization law that was enacted.

In November, regulators also approved rules for the state’s cannabinoid hemp program, notably clarifying that flower from the crop can be sold but delta-8 THC products are currently prohibited from being marketed.

“Launching the new patient certification and registration system and expanding eligibility for the Medical Cannabis Program are significant steps forward for our program,” OCM Executive Director Chris Alexander said. “We will continue to implement the MRTA and ensure that all New Yorkers who can benefit from medical cannabis have the access they need to do so.”

“It’s important for New Yorkers to know that even as we shift the medical program to the OCM, your access will not be disrupted and the program will continue to expand,” he stressed.

While marijuana retailers have yet to launch in New York, the legalization law signed by former Gov. Andrew Cuomo (D) already permits adults 21 and older to possess and publicly consume cannabis. Meanwhile, lawmakers in the state have been working to build upon the reform.

For example, a New York senator filed a bill last month to make it so that gay, lesbian and bisexual people can qualify as social equity applicants under the state’s marijuana law.

Sen. Jeremy Cooney (D) introduced the legislation, shortly after filing a separate bill to include transgender and non-binary people in the cannabis social equity program. He’s also behind other recent marijuana reform proposals related to cannabis business tax benefits and licensing.


Marijuana Moment is already tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

In July, Cooney filed a bill to create a provisional marijuana licensing category so that farmers could begin cultivating and selling cannabis ahead of the formal rollout of the adult-use program.

Cooney is also sponsoring a newly filed bill to allow licensed cannabis companies to deduct certain business expenses on their state tax returns.

Gov. Kathy Hochul (D), who replaced Cuomo after he resigned amid a sexual harassment scandal, has repeatedly emphasized her interest in efficiently implementing the legalization law.

Hochul released a State of the State book earlier this month that called for the creation of a $200 million public-private fund to specifically help promote social equity in the state’s burgeoning marijuana market.

The governor said that while cannabis business licenses have yet to be approved since legalization was signed into law last year, the market stands to generate billions of dollars, and it’s important to “create opportunities for all New Yorkers, particularly those from historically marginalized communities.”

That proposal was also cited in Hochul’s executive budget, which was released last week. The budget also estimated that New York stands to generate more than $1.25 billion in marijuana tax revenue over the next six years.

The state Department of Labor separately announced in recent guidance that New York employers are no longer allowed to drug test most workers for marijuana.

Meanwhile, a New York lawmaker introduced a bill in June that would require the state to establish an institute to research the therapeutic potential of psychedelics.

Another state legislator filed legislation last month to legalize psilocybin mushrooms for medical purposes and establish facilities where the psychedelic could be grown and administered to patients.

Colorado Meets Marijuana Industry Diversity Goal Ahead Of Schedule

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Colorado Meets Marijuana Industry Diversity Goal Ahead Of Schedule

Published

on

Colorado officials announced on Monday that the state has achieved a “wildly important goal” of increasing diversity in the legal marijuana industry—but the data shows there’s still a way to go before cannabis business ownership is on par with the state’s population demographics.

Nearly 17 percent of the state’s cannabis businesses are now minority-owned as of January 1, the Marijuana Enforcement Division (MED) reported. Colorado had set a goal of at least 16.8 percent minority ownership in the cannabis sector by June 30, 2022, and that’s already been narrowly exceeded by the beginning of the year.

When data on licensee demographics started to be collected in July 2021, there was 15.2 percent minority ownership in the marijuana market. Now it’s up to 16.8 percent.

As of January 1, the state has also approved 50 social equity licenses for communities disproportionately impacted by prohibition.

Via Colorado DOR.

As one of the first states to legalize marijuana for adult use, there’s been significant pressure on Colorado to ensure that the industry is equitable, benefitting those who have been most impacted under criminalization.

“Colorado is demonstrating that intentionally revising state marijuana laws to be more equitable gets results,” Shaleen Title, a former Massachusetts cannabis regulator and current CEO of the Parabola Center, told Marijuana Moment.

“If one of the most mature markets can make clear progress, it’s not too late for any market. And although there’s always more to go—we should all be aiming for proportional representation in ownership at the very least—Colorado is setting and reaching reasonable goals,” she said. “It’s good for transparency and it’s good for morale, and having more data on what’s working at the state level is valuable to inform federal policy.”

(Disclosure: Title supports Marijuana Moment’s work via a monthly pledge on Patreon.)

A demographic breakdown of the new data shows that while there’s been an increase in minority ownership, the percentage of black people who own a majority stake in a cannabis business (2.9 percent) is still lower than the percentage of black people who live in the state (4.6 percent).

There’s also a significant disparity when it comes to gender and marijuana licensing. MED’s report says that there are 1,535 men who own a marijuana business, compared to just 350 women.

And with respect to license type, white people have a notably more expansive portfolio compared to other races.

Via MED.

Colorado Gov. Jared Polis (D) is also working to right the wrongs of prohibition outside of licensing. For example, last month he granted 1,351 pardons for convictions of possession of two ounces or less of marijuana.

That move focused on people who were made eligible for relief under a new law that increased the legal cannabis possession limit for adults in the state, which Polis signed in May. At the time, he directed state law enforcement to identify people with prior convictions for amounts under the new, two-ounce limit.

Polis signed an executive order in 2020 that granted clemency to almost 3,000 people convicted of possessing one ounce or less of marijuana. And while earlier legislation that enabled him to do that in an expedited way applied to possession cases involving up to two ounces, his office declined to pardon those with more than one ounce on their records because that amount violated the existing state law.

As the state works to increase diversity in the marijuana industry, it’s also collecting significant tax revenue from cannabis sales.

Last year alone, Colorado generated $423 million in tax revenue from cannabis, the state’s Department of Revenue reported last week.

Nearly $500 million of cannabis tax revenue in Colorado has supported the state’s public school system so far, according to a report from the Marijuana Policy Project.

Massachusetts Marijuana Tax Revenue Now Exceeds Alcohol By Millions

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Governors Across The U.S. Tout Marijuana Reform Progress In State Of The State Speeches And Budgets

Published

on

Governors across the U.S. have been taking the opportunity to tout marijuana reform accomplishments as part of their annual State of the State speeches and budget requests this month.

From New York to South Dakota, the comments and proposals from state executives demonstrate how cannabis has become more mainstream and is being talked about in high profile venues alongside more traditional fare such as taxes, education and infrastructure.

It’s also part of a growing theme, as governors have increasingly brought up marijuana policy in State of the State addresses each year to kick off the new year as the legalization movement spreads.

Here’s a look at what governors are saying about marijuana policy in 2022: 

New Jersey

While adult-use marijuana retail sales have yet to launch in New Jersey after voters approved a 2020 legalization referendum, the state’s top executive said in his State of the State address that he’s expecting an economic boon.

“Many jobs await in the cannabis industry ready to take off,” Gov. Phil Murphy (R) said.

The governor also said separately in his second inaugural address this month that “businesses in the new cannabis industry that we are setting up in the name of social justice” are part of efforts to “continue growing the innovation economy that will power our future and make us a model for the nation and the world.”

As the state prepares to implement legal cannabis sales, Murphy said late last year that he’s open to giving adults the right to cultivate marijuana for personal use even though it’s not currently written into the law.

New Mexico

New Mexico Gov. Michelle Lujan Grisham (D) talked in here State of the State speech about the economic potential of the marijuana industry under the legalization law she signed last year.

“We’re expanding our economic footprint into every single community,” the governor said in her State of the State address. “Legal cannabis is going to create thousands of jobs and serious tax revenue for local governments to support local services in every corner of our state.”

New York

New York Gov. Kathy Hochul (D) released a State of the State book earlier this month that called for the creation of a $200 million public-private fund to specifically help promote social equity in the state’s burgeoning marijuana market.

The governor said that while cannabis business licenses have yet to be approved since legalization was signed into law last year, the market stands to generate billions of dollars, and it’s important to “create opportunities for all New Yorkers, particularly those from historically marginalized communities.”

That proposal was also cited in Hochul’s executive budget, which was released last week. The budget also estimated that New York stands to generate more than $1.25 billion in marijuana tax revenue over the next six years.

The briefing book for the executive budget touts how Gov. Kathy Hochul (D) has “prioritized getting New York’s cannabis industry up and running” since marijuana was legalized under her predecessor last year. That includes appointing key regulators who’ve been “creating and implementing a comprehensive regulatory framework.”

Rhode Island

The governor of Rhode Island included a proposal to legalize marijuana as part of his annual budget plan—the second time he’s done so. And time around, he also added new language to provide for automatic cannabis expungements in the state.

Gov. Dan McKee (D) released his request for the 2023 fiscal year on Thursday, calling for adult-use legalization as lawmakers say they’re separately nearing a deal on enacting the reform. It appears that an outstanding disagreement between the governor and legislators concerning what body should regulate the program remains unresolved based on the new budget proposal, however.

In general, McKee’s plan would allow adults 21 and older to purchase and possess up to one ounce of cannabis, though it would not provide a home grow option. Adults could also store up to five ounces of marijuana in secured storage in their primary residence.

“The governor recommends creating a strictly regulated legal market for adult-use cannabis in the state,” an executive summary states. “This proposal would create a weight-based excise tax on marijuana cultivation, an additional retail excise tax of 10 percent, and also apply sales tax to cannabis transactions.”

South Dakota

South Dakota Gov. Kristi Noem (R) isn’t a fan of adult-use legalization, going so far as to fund a lawsuit against a voter-approved 2020 reform initiative that ultimately led to a court ruling voiding the law. Her office has even suggested that activists behind the successful legalization campaign should front the legal bills for the case.

However, she seems to recognize the popularity of the issue and has recently attempted to associate herself with the implementation of the separate medical cannabis legalization law that voters also approved, as she did in her State of the State address this month.

“I take our citizens’ health seriously. I don’t make these decisions lightly. And when we create new policy, we’re going to do everything we can to get it right from day one,” Noem said. “Our state’s medical cannabis program is one example.”

“It was launched on schedule according to the timeline passed by South Dakota voters,” she said. “I know there will be some debate about that program this session. My focus is on making sure South Dakota has the safest, most responsible, and well-run medical cannabis program in the country.”

Noem tried to get the legislature to approve a bill to delay implementation of the medical cannabis program for an additional year, but while it cleared the House, negotiators were unable to reach an agreement with the Senate in conference, delivering a defeat to the governor.

In response, her office started exploring a compromise last year, with one proposal that came out of her administration to decriminalize possession of up to one ounce of cannabis, limit the number of plants that patients could cultivate to three and prohibit people under 21 from qualifying for medical marijuana.

Advocates weren’t enthused with the proposal, and now they’re taking a two-track approach to enacting broader legalization legislatively and through the ballot.

Virginia

In his final State of the Commonwealth address this month, now former-Gov. Ralph Northam (D) talked about the criminal justice implications of his state’s move to legalize marijuana last year.

“We also worked closely with you to make sure our criminal justice system reflects the Virginia that we are today. Too often, our modern-day punishments and practices have their roots in a more discriminatory and unfair past,” he said. “That’s why we’ve made marijuana use legal.”

He also thanked the legislators who championed the reform “for their work on this policy, which is complicated, but important.”

Meanwhile, the new governor of Virginia, Glenn Youngkin, said recently that while he’s not interested in re-criminalizing marijuana possession, which became legal in the state last summer, but he feels there’s “still work to be done” before he gets behind creating a market for commercial sales and production.

Bipartisan Pennsylvania Senators File Bill To Let Medical Marijuana Patients Grow Their Own Plants

Photo courtesy of Mike Latimer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Marijuana Moment